Caxton Corp as of June 30, 2024
Portfolio Holdings for Caxton Corp
Caxton Corp holds 12 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 58.3 | $12M | 5.1M | 2.25 | |
| Rezolute Com New (RZLT) | 28.7 | $5.7M | 1.3M | 4.30 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 5.2 | $1.0M | 1.9k | 544.10 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 2.1 | $417k | 1.0k | 406.90 | |
| Lexeo Therapeutics (LXEO) | 1.5 | $286k | 18k | 16.04 | |
| Mind Medicine Com New (MNMD) | 1.1 | $219k | 30k | 7.21 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.9 | $184k | 14k | 13.22 | |
| Kyverna Therapeutics (KYTX) | 0.9 | $172k | 23k | 7.50 | |
| Molecular Templates Com New (MTEMQ) | 0.8 | $157k | 137k | 1.15 | |
| Compass Therapeutics (CMPX) | 0.2 | $44k | 44k | 1.00 | |
| Context Therapeutics (CNTX) | 0.2 | $37k | 18k | 2.01 | |
| Adicet Bio | 0.1 | $21k | 18k | 1.21 |
